India plans 30% trade margin cap on cancer drugs to cut prices
The Indian government intends to impose a cap on trade margins for all cancer medications. This policy aims to significantly reduce drug prices and improve patient affordability. The move could lead to annual patient savings of approximately Rs 2,500 crore. An expert committee will determine which specific drugs will be covered under the new regulation.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)
Log in to join the discussion and vote.
Log in